![](/img/cover-not-exists.png)
OL-010 Sequential use of nitazoxanide (NTZ) as a salvage therapy in patient with recurrent mild to moderate Clostridium difficile infection (CDI): a prospective, open-label, randomized clinical trial
P.P. Basu, N.J. Shah, N. Krishnaswamy, R. Korapati, S. Tammisetti, C.C. TangVolume:
14
Year:
2010
Language:
english
DOI:
10.1016/s1201-9712(10)60014-8
File:
PDF, 45 KB
english, 2010